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Changes occurring in the activity of porcine pancreatic phospholipase A 2 upon formation of mixed micelles of sodium 
cholate and the fluorescent phosphocholines 1,2-di [6-(pyren-l-yl)butanoyl]-sn-glycero-3-phosphocholine r 1-[6-(pyren- 
1-yl)butanoyl]-2-[6-(pyren-1-yl)hexanoyl]-sn-glycero-3-phosphochofine were studied. A 2-fold enhancement was observed 
in the activity of phospholipase A~ towards both pyrene phospholipids upon exceeding the critical micellar concentration 
of the system. Changes in the pyrene xcimer/monomer fluorescence emission intensity ratio coincide with the enhance- 
ment of phospholipase A 2 activity at the critical mieellar concentration. Due to the different effects of micellization on 
the alignment of the pyrene in the two fluorescent probes conformational changes could be assessed. A model describing 
possible conformations of these pyrene phospholipid molecules below and above the critical micellar concentration is 
presented and correlated with the interfacial activation of phospholipase A 2. 
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1. INTRODUCTION 
Phospholipase A2 (EC 3.1.1.4, PLA2) catalyzes 
the hydrolysis of the sn-2 fatty acyl ester bond of 
sn-3 phospholipids [1]. PLAzs are most abundant- 
ly present in pancreas and in venoms of snakes [2]. 
Pancreatic PLA2 is secreted as a zymogen having 
a fully functioning active site whereas nake venom 
PLA2s have not been found to have a proenzyme 
form [2]. A characteristic feature in the kinetics of 
PLA2 is their activation at the critical micellar con- 
centration (CMC) of the substrate (review [21). 
Substrate concentration vsenzyme activity curves 
show a break at the CMC of the substrate il- 
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lustrating this phenomenon and even 104-times 
higher activities are observed towards substrates 
present in lipid-water interfaces than towards the 
same phospholipids in monomeric solutions. 
However, the zymogen of pancreatic PLA2 is not 
activated at interfaces [3]. The most feasible ex- 
planations for the interfacial activation are: (i) the 
substrate theory which assumes substrate 
molecules to be in interfaces ina conformation dif- 
ferent from that in monomolecular solutions and 
resulting in an enhanced PLA2 activity [4-7] or 
alternatively, assumes the dehydration of inter- 
facial substrate to be responsible for the interfacial 
activation [8-11] and (ii) the enzyme theory which 
assumes a conformational change in the enzyme 
molecule upon adsorption to the interface 
[3,12,13]. These models are not mutually ex- 
clusive. Despite extensive studies no definitive 
agreement exists on the molecular mechanism of 
this phenomenon (reviews [2,14-17]). However, it 
is generally agreed that the 'quality' of the inter- 
face plays an important role in determining the ac- 
tivity of PLA2 [2,18]. 
We have presented evidence that the activities of 
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phospholipases A1 and A2 can be reciprocally 
regulated by changing the physical state of the 
substrate and proposed a model for conforma- 
tional changes occurring in phospholipid 
molecules [19,20]. In our earlier study, however, 
liposomal and monolayer membranes were used to 
characterize lectrostatically [21] induced altera- 
tions in substrate phospholipids and in PLA2 ac- 
tivities [19,20]. Therefore, the direct relevance of 
these results to the elucidation of the mechanism 
underlying PLA2 activation at the CMC is ques- 
tionable as changes in the degree of substrate 
deprotonation were involved [21]. We have also 
shown that PLAx and PLA2 activities can be 
regulated by 'vertical compression' of the substrate 
monolayer altering the conformation of the 
substrate phospholipids [22]. Recently we have 
observed that PLA2 activity towards phospholipid 
monolayers can be triggered by an electric field 
across the substrate monolayer [23]. 
Here, constant submicellar concentrations of 
dipyrenephosphocholines were maintained while 
varying the concentration of sodium cholate from 
zero to values above the CMC. This allows one to 
observe changes in fluorescence of the pyrene 
phospholipids upon formation of mixed sodium 
cholate-phospholipid micelles thus reflecting 
changes in the conformation of pyrene 
phospholipids and to correlate these changes to 
PLA2 activation at the CMC. 
2. EXPERIMENTAL 
The fluorescent lipids diPBPC and PBPHPC were purchased 
from KSV Chemical Corp. (Hdsinki). Porcine pancreatic PLA2 
was from Sigma and revealed a single Coomassie brilliant blue- 
stained band upon polyacrylamide g l electrophoresis in the 
presence of SDS [24]. 
Pyrene excimer (I0 and monomer (Ira) fluorescence emission 
intensities were measured with an SLM 4800S spec- 
trofluorometer using averaging of 100 signals. The excitation 
wavelength was 343 nm and emission wavelengths were 396 and 
480 nm for Im and Ie, respectively. Emission intensities were 
corrected for background ue to sodium cholate. 
PLA2 activities were determined with a Kontron SFM 23 
spectrofluorometer as described [19,25,26]. The substrate was 
prepared by drying 10/zg pyrenephosphocholine witha gentle 
stream of nitrogen. Thereafter the lipid was dissolved in 1.0 ml 
of 20 mM Tris-HC1, pH 8,0, buffer by brief sonication. 100/d 
of the substrate solution was added in 1.9 ml of 20 mM Tris- 
HCI/4 mM CaCI2, pH 8.0, buffer containing the indicated 
amounts of sodium cholate. The addition of the enzyme started 
the reaction. The reaction was followed by recording the incre- 
ment of the fluorescence emission intensity of pyrene monomer 
at 400 nm due to enzyme action. The excitation wavelength was 
343 nm. The enzyme reaction was linear for at least 5 min and 
the activities were calculated from the linear portion of the 
curves. 
CMCs were determined by measuring the surface tension of 
the air-water interface using the Wilhelmy plate method as a 
function of the subphase lipid or cholate concentration using 
the KSV 2200 Surface Barostat system (KSV Chemical Corp.). 
3. RESULTS 
The CMCs of diPBPC and PBPHPC were 5.1 
and 3.2/aM, respectively, and thus clearly above 
the concentration of 0.63/aM for diPBPC and 0.61 
/aM for PBPHPC used in the present study. The 
CMC of diPBPC agrees with that reported earlier 
[27]. The CMCs of sodium cholate in the presence 
of 0.63/aM diPBPC and with 0.61/aM PBPHPC 
were 4.2 and 3.9 raM, respectively, in agreement 
with earlier observations on the CMC of sodium 
cholate in a different solvent [28]. 
The activity of PLA2 towards 0.63/zM diPBPC 
as a function of sodium cholate concentration ex- 
hibited a break at approx. 4.0 mM cholate in good 
agreement with the CMC of sodium cholate ob- 
tained with the monolayer technique (fig. 1, left). 
At 4.0 mM sodium cholate PLA2 activity increased 
approx. 2-fold. The Ie/Im of 0.63/aM diPBPC ex- 
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Fig. 1. (Left) Activity of phospholipase A2 towards diPBPC and 
pyrene Ie/Im of diPBPC as a function of sodium cholate 
concentration. (Right) Activity of phospholipase A2 towards 
PBPHPC and le/Im of PBPHPC as function of sodium cholate 
concentration: Reaction mixture contained 1.25 nmol diPBPC 
or 1.21 nmol PBPHPC in 2.0 ml of 20 mM Tris-HCl 4.0 mM 
CaCI2, pH 8.0, buffer and the indicated amounts of sodium 
cholate. In enzyme assays the reaction mixture contained in 
addition to the above mixture 0.1 /zg (7 pmol) porcine 
pancreatic phospholipase A2 in 20/~l of 20 mM Tris-HCl, pH 
8.0. Temperature, 37°C. 
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hibited very high values between 9.5 and 10.5 when 
the cholate concentration varied between 0 and 3 
mM (fig. 1, left). When the cholate concentration 
was increased from 3.5 to 5.0 mM Ie/Im decreased 
rapidly and levelled off to a value of 3.7 at 10 mM 
cholate. 
Fig. 1 (right) illustrates Ie/Im and PLA2 activity 
towards 0.61 /zM PBPHPC as a function of 
sodium cholate concentration. As in the case of 
diPBPC PLA2 was activated approx. 2-fold when 
the cholate concentration exceeded 4.0 mM. 
Cholate concentrations above 6.0 mM caused 
PLA2 activity to decrease. Without he addition of 
cholate IJIm had a value of 11.5 and the highest 
value of IJIm, 13.5, was observed with 0.5 mM 
cholate. When the cholate concentration was in- 
creased further, up to 3.5 mM, Ie/Im decreased 
steadily to 10.0. A plateau in Ie/Im was observed 
between 3.5 and 4.5 mM cholate. Above 4.5 mM 
cholate I~/Im decreased again and at 10 mM 
cholate the Ie/Im value was 7.5. 
4. DISCUSSION 
On the basis of results from NMR studies the 
conformation of phospholipid molecules in 
micelles has been suggested to differ from that in 
monomers [29-31]. However, contradictory esults 
have also been reported [32,33]. Phospholipids 
have been suggested toadopt he so-called 'kinked' 
conformation in micelles [29-31] and X-ray 
crystallography studies on the conformation of 
phosphatidylcholine and phosphatidylglycerol 
have revealed that phospholipid molecules do 
adopt this conformation i lipid crystals [34-36]. 
In the kinked conformation the sn-2 acyl chain 
begins perpendicularly to the glycerol backbone 
and after the first two methylene segments bends 
to align the sn-1 chain and parallels the glycerol 
backbone. Notably, according to the X-ray dif- 
fraction data on PLA2 the substrate should be in 
the kinked conformation i order to fit optimally 
into the active site of PLA~ [37]. 
The present study was undertaken to investigate 
the possible conformational changes of pyrene 
phospholipids upon formation of sodium cholate- 
pyrenephosphocholine mixed micelles and the 
simultaneous interfacial activation of PLA2. The 
pyrene phospholipid analogs can give rise to the 
formation of excited dimer, excimer [38,39]. 
Therefore, these fluorescent phospholipids can 
emit light at 400 and 480 nm corresponding to 
pyrene monomer and excimer emission, respective- 
ly. The dipyrene phospholipids diPBPC and 
PBPHPC were chosen due to their ability to form 
intramolecular excimer [39] in addition to the in- 
termolecular excimer and due to their different 
pyrene fatty acyl chains at the sn-2 position. We 
previously concluded that changes in in- 
tramolecular excimer formation can reflect 
changes in the conformation of dipyrene 
phospholipids [19,20,40]. If the model of the ex- 
tended and kinked conformations of these pyrene 
phospholipids below and above CMC, respective- 
ly, were to be operative, a decrement in the rate of 
intrarnolecular pyrene excimer formation of 
diPBPC above CMC would be observed ue to the 
non-alignment of the pyrene moieties at the end of 
the fatty acyl chains in the kinked conformation 
(fig.2). If a similar conformational change takes 
place in PBPHPC it should result in an increase in 
intramolecular pyrene excimer formation due to 
the shift of the pyrene moiety at the end of the 
longer sn-2 hexanoyl chain to align the pyrene 
moiety at the end of the sn-1 butanoyl chain 
(fig.2). Simultaneously with the changes in the 
fluorescence ofpyrene phospholipids an activation 
of PLA2 should be seen. 
As is clear from fig.1 a 2-fold activation of 
PLA2 was observed upon formation of mixed 
micelles. The activation should be analogous to the 
interfacial activation upon phospholipid micelliza- 
tion [1,2,41]. Although pure PBPHPC was 
hydrolyzed at a 2-fold higher rate than pure 
diPBPC the activities of PLA2 towards both 
pyrene phospholipids were approximately equal 
above the CMCs of the two systems, indicating 
that in mixed micelles the substrate properties of 
these lipids were similar. For both lipids the 2-fold 
activation of PLA2 could thus reflect the 
preference of the active site of the enzyme for the 
kinked conformation [37]. The reason for the 
slight decrease in PLA2 activity towards PBPHPC 
for increasing cholate concentrations above the 
CMC is at present unknown. 
Phospholipids have been suggested to form 
premicellar aggregates below the CMC [42]. 
Changes in the very high Ie/Im observed in the 
presence of submicellar cholate suggested the for- 
mation of premicellar molecular aggregates by 
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Fig.2. A model for conformational changes indiPBPC and PBPHPC upon formation ofmixed micelles with cholate. Sodium cholate 
concentration s given in mM. Phospholipase A2 activities are expressed as/zmol, min -1- mg -1. 
both pyrene phospholipids [42]. Therefore, 
changes in Ie/Im are likely to be due to changes in 
both inter- and intramolecular excimer formation 
rates [19,20, 38-40]. When the premicellar pyrene 
phospholipid aggregates disappear at CMC and 
pyrenephosphocholine molecules were distributed 
to mixed micelles by increasing cholate concentra- 
tions a decrement in 1=/lol should be seen. This is 
due to the increased distance between each 
pyrenephosphocholine molecule resulting in a 
decrement in the intermolecular pyrene excimer 
formation rate. Above CMC the local concentra- 
tion of the pyrene phospholipid molecules was very 
low in the mixed miceUes, the average number of 
pyrenephospholipid molecules in each micelle be- 
ing less than unity [28]. 
Upon formation of mixed micelles the rapid 
decrease in the Ie/Im of diPBPC would, therefore, 
be due to the decrement in both intra- and inter- 
molecular excimer fluorescence (fig.2) whereas the 
plateau observed in the le/lm of PBPHPC upon 
micelle formation should arise from the reciprocal 
effects of decreasing intermolecular nd increasing 
intramolecular excimer formation. The observed 
changes in the intramolecular excimer fluorescence 
of both pyrenephosphocholines upon micelle for- 
mation suggest changes in the conformation of 
these phospholipids. In submicellar solutions 
phospholipids would have their acyl chains more 
or less parallel to each other and perpendicular to
the glycerol backbone (fig.2) [29-31]. Upon for- 
mation of mixed micelles both pyrene 
phospholipids would adopt the kinked conforma- 
tion resulting in a decrease in intramolecular ex- 
cimer formation of diPBPC and an increase in that 
of PBPHPC, thus agreeing with the assumptions 
made on the basis of the model (fig.2). 
These results can be taken to support the 
'substrate theory' of PLA2 activation at the CMC 
[4-11] as they reflect changes in the conformation 
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of phospholipids due to incorporation of the lipid 
into a mixed micelle. The observed changes in the 
lipid conformation i fluencing the action of PLA2 
also seem to be in line with our earlier model 
developed on the basis of results from a distinctly 
different experimental pproach [20,21]. The pre- 
sent study may now justify the extension of our 
previous model to concern changes in the confor- 
mation of phospholipids and the mechanism of the 
interfacial activation of PLA2 at the CMC. 
However, these results do not exclude a 
simultaneous conformational change in the en- 
zyme upon adsorption i to the substrate interface 
also contributing to the enhanced activity of PLA2 
[3, 12,13]. 
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